Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Operating Expenses: 2014-2017

  • KalVista Pharmaceuticals' Other Operating Expenses was N/A to -$9.6 million in Q1 2017 from the same period last year, while for Jan 2017 it was -$8.1 million, marking a year-over-year change of. This contributed to the annual value of -$53.4 million for FY2025, which is 49.25% down from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Other Operating Expenses of -$9.6 million as of Q1 2017, which was down 956,500.00% from $1,000 recorded in Q4 2016.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Operating Expenses peaked at $3.8 million during Q4 2014, and registered a low of -$9.6 million during Q1 2017.
  • Moreover, its 3-year median value for Other Operating Expenses was $0 (2015), whereas its average is -$2.0 million.
  • Data for KalVista Pharmaceuticals' Other Operating Expenses shows a maximum YoY slumped of 100.03% (in 2015) over the last 5 years.
  • Quarterly analysis of 4 years shows KalVista Pharmaceuticals' Other Operating Expenses stood at $3.8 million in 2014, then plummeted by 100.03% to -$1,000 in 2015, then reached $1,000 in 2016, then reached -$9.6 million in 2017.
  • Its Other Operating Expenses was -$9.6 million in Q1 2017, compared to $1,000 in Q4 2016 and $1.5 million in Q1 2016.